[Gastrointestinal complication of cancer chemotherapy].
Hamaguchi
Tetsuya
T
First Outpatient Division, National Cancer Center Hospital.
D000932:Antiemetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077608:Aprepitant; D003967:Diarrhea / Q000139:chemically induced* / Q000145:classification / Q000628:therapy; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy; D000077924:Palonosetron; D011812:Quinuclidines / Q000627:therapeutic use; D012306:Risk; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013280:Stomatitis / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy; D014839:Vomiting / Q000139:chemically induced* / Q000188:drug therapy
D000932:Antiemetics; D000970:Antineoplastic Agents; D007546:Isoquinolines; D009025:Morpholines; D011812:Quinuclidines; D012702:Serotonin Antagonists; D000077608:Aprepitant; D000077924:Palonosetron